FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.
Biotech firm CSL (CSL.AX), opens new tab said on Thursday its vaccine arm, CSL Seqirus and Vaccine Industrial Company, had inked a deal with Saudi Arabia’s Health Ministry to localize manufacturing of cell-based seasonal and pandemic influenza vaccines.
The deal comes a few days later after Australia’s CSL said it was no longer targeting to complete the spin off of Seqirus in fiscal 2026 amid heightened volatility in the U.S. vaccine markets
Popular Categories
© All content and intellectual rights of this website belong to Fansalaran — Website design and SEO by Omid Esmaeili.
